Literature DB >> 6384050

Immunoglobulin G and M composition of naturally occurring antibody to type III group B streptococci.

B F Anthony, N F Concepcion, C A Wass, D C Heiner.   

Abstract

Human sera were examined by an enzyme-linked immunosorbent assay for immunoglobulin G (IgG) and IgM antibodies to purified type III polysaccharide of group B streptococci. The antigen-binding capacity of a reference human serum was determined by a radioimmunoassay, and the total antibody content was determined by quantitative precipitation. The serum was then depleted of IgM and IgA to determine the effect on the antigen-binding capacity. Duplicate samples of 81 sera were tested by the enzyme-linked assay in comparison with reference standard serum. Although levels of IgG antibody were greater in subjects who had carried type III streptococci during pregnancy, concentrations of this antibody were generally low. Only 2 of 28 sera (7%) from parturient subjects and 7 of 25 sera (28%) from adult volunteers contained greater than or equal to 1 microgram of IgG antibody per ml; the mean levels were 0.13 and 0.53 micrograms/ml, respectively. In contrast, 19 of 28 maternal sera (68%) and 22 of 25 (88%) volunteer adult sera contained greater than or equal to 1 microgram/ml of IgM antibody; mean levels were 1.33 and 1.54 micrograms/ml, respectively. The cord serum levels of IgG antibody were almost identical to maternal serum concentrations, whereas IgM antibody was essentially undetected.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6384050      PMCID: PMC261427          DOI: 10.1128/iai.46.1.98-104.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

2.  Coupling of enzymes to proteins with glutaraldehyde. Use of the conjugates for the detection of antigens and antibodies.

Authors:  S Avrameas
Journal:  Immunochemistry       Date:  1969-01

3.  Method for differentiation of nonspecific from specfic toxoplasma IgM fluorescent antibodies in patients with rheumatoid factor.

Authors:  B Hyde; E V Barnett; J S Remington
Journal:  Proc Soc Exp Biol Med       Date:  1975-04

4.  The specificity of fetal IgM: antibody or anti-antibody?

Authors:  C B Reimer; C M Black; D J Phillips; L C Logan; E F Hunter; B J Pender; B E McGrew
Journal:  Ann N Y Acad Sci       Date:  1975-06-30       Impact factor: 5.691

5.  Radioimmunoassay for measuring antibodies specific for group B streptococcal types Ia, Ib, Ic, II, and III.

Authors:  H W Wilkinson; W L Jones
Journal:  J Clin Microbiol       Date:  1976-05       Impact factor: 5.948

6.  Serologic studies of meningococcal infection and polysaccharide vaccination.

Authors:  M S Artenstein; B L Brandt; E C Tramont; W C Branche; H D Fleet; R L Cohen
Journal:  J Infect Dis       Date:  1971-09       Impact factor: 5.226

7.  Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection.

Authors:  C J Baker; D L Kasper
Journal:  N Engl J Med       Date:  1976-04-01       Impact factor: 91.245

8.  Quantitative determination of the human immune response to immunization with meningococcal vaccines.

Authors:  E C Gotschlich; M Rey; R Triau; K J Sparks
Journal:  J Clin Invest       Date:  1972-01       Impact factor: 14.808

9.  Quantitative determination of antibody to capsular polysaccharide in infection with type III strains of group B Streptococcus.

Authors:  C J Baker; D L Kasper; A Paredes; S Alpert; W M McCormack; D Goroff
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

10.  Group A streptococcal antigens cross-reactive with myocardium. Purification of heart-reactive antibody and isolation and characterization of the streptococcal antigen.

Authors:  I van de Rijn; J B Zabriskie; M McCarty
Journal:  J Exp Med       Date:  1977-08-01       Impact factor: 14.307

View more
  3 in total

1.  Measurement of human antibodies to type III group B Streptococcus.

Authors:  D L Kasper; M R Wessels; H K Guttormsen; L C Paoletti; M S Edwards; C J Baker
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

2.  Seroepidemiology of group B Streptococcus type II antibody specificity.

Authors:  B M Gray; D G Pritchard; J D Springfield; R J Benak; H C Dillon
Journal:  Epidemiol Infect       Date:  1988-10       Impact factor: 2.451

3.  Isotype composition of antibodies to streptococcus group B type III polysaccharide and to tetanus toxoid in maternal, cord blood sera and in breast milk.

Authors:  T Lagergård; K Thiringer; L Wassén; R Schneerson; B Trollfors
Journal:  Eur J Pediatr       Date:  1992-02       Impact factor: 3.183

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.